Navigation Links
Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
Date:9/10/2008

ANTONY, France, September 10 /PRNewswire-FirstCall/ -- Stallergenes S.A. officially inaugurates its new pharmaceutical production unit, located in the Paris area.

Designed to comply with the most stringent EMEA (European Medicines Agency) and FDA (US Food and Drug Administration) standards, this unit will produce desensitisation treatments for all markets, primarily in Europe and North America.

This investment worth more than 20 million euros will incorporate the production of the active substance for the Oralair(R) Grasses tablet and increase the production capacity for Staloral(R), to meet the needs of an expanding international marketplace.

"For Stallergenes, this investment marks a major step forward. This new production unit will help the company break into the tough U.S market and increase its production capacity tenfold," states Albert Saporta, Chairman and CEO of Stallergenes.

ABOUT ORALAIR(R) GRASSES

Oralair(R) Grasses is a fast-dissolving sublingual desensitisation tablet indicated in allergic rhino-conjunctivitis caused by grass pollen for patients with moderate to severe symptoms unsatisfied with or inadequately controlled by symptomatic treatments. Oralair(R) Grasses contains a mix of five standardised grass allergens, mimicking patients' natural exposure: perennial rye grass (Lolium perenne), meadow grass (Poa pratensis), timothy grass (Phleum pratense), cocksfoot (Dactylis glomerata) and sweet vernal grass (Anthoxanthum odoratum). In June 2008, Oralair(R) Grasses was granted a marketing authorisation in adults in Germany and a paediatric extension of its indications is expected by the end of the year. Stallergenes then plans to launch a mutual recognition procedure in the near future, with a view to marketing Oralair(R) Grasses in other European countries in both indications.

ABOUT Staloral(R)

Staloral(R) is an NPP (named patient product) sublingual solution (drops to be placed under the tongue)
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
2. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
3. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
4. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
5. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
6. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
7. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
8. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
9. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
10. Eyeforpharmas Marketing Summit is shaping up to be the biggest event of its kind ever
11. Panacea Pharmaceuticals Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazines Ten Biggest Medical Breakthroughs of 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...v. 30 Cell Therapeutics,... that its new class of platinum-based anti-tumor c...ronger anti-tumor potency and activity compared to...ell as the ability to overcome cisplatin-resistanc...d in a paper titled "Novel Bis-platinum Complexes ...
(Date:11/30/2009)...ON, November 30 ApaTech, the rapid...e,s fastest growing,Biotech/Pharmaceutical/Medical... Technology Fast 500 for EMEA (Europe, Middle East...sed on a companies, five-year revenue growth,for ...his period. This,achievement places ApaTech 9th ov...
(Date:11/28/2009)... Vanuatu National Advisory Committee on Climate Ch...tion (SNC) Project in collaboration with the Vanua... New Zealand have generated preliminary climate ch... background for the country’s SNC reporting ...ate Change (UNFCCC). , P...
(Date:11/27/2009)...echanised blue dye test alternative is helping b...rance one step closer for pharma-companies. It is ...ine developed by Sepha for use with blister pack...al and global pharma-companies such as Sanofi-Aven...and productivity improvements on the packaging lin...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3
...4 Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ...g,developing and commercializing proprietary produ...setting, announced today that the company,s,Presid...mpany,s corporate,overview at the following invest...cialty Pharmaceuticals Conference at the South...
...nues - a record $35.5 million vs. $24.7 million in...43.4%, Q2 2008 Diluted Net Income per Share - $0... increase of 62.5% Q2 2008 Operating Inco...New Bookings of $49.0 million vs. $34.5 million in...gy,Inc. (eRT), (Nasdaq: ERES ), a leading provide...
...., Aug. 4 Telik, Inc.,(Nasdaq: TELK ) announced ...ebcast will be held on Monday, August 11, 2008 at ...llowing the release earlier that day of the,compan... June 30, 2008., The conference call will be acce...m or by telephone at 800-553-5260 or 612-332-0720...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008 2eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9
(Date:11/30/2009)...Those extra helpings of gravy and dessert at the h...line than previously thought. According to a new r...ASEB Journal ( http://www.fasebj.org ), a diet th...n genes that ultimately cause our bodies to store ...a double-whammy as the already difficult task of c...
(Date:11/30/2009)... This release is available in German . , Th...laborative Research Centres as of 1 January 2010. ...ants Committee in Bonn. The new centres will initi...million. In addition, 20 percent overhead funding ...project. The centres, research topics range from m...
(Date:11/30/2009)...HOBOKEN, N.J. - The inaugural Global Conference o...r 3-4, 2009, in Washington, DC, focuses on the con...rises of critical importance to society. , T...of research activity around targeted complex syste...s year,s topic includes Critical Infrastructure Sy...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 1Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 2Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 3Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 4Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 5Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 6Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 7Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 8Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 9Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 10Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 11Upcoming trends in hematological malignancies 58028 1IOM report released on species jumping diseases 58026 1IOM report released on species jumping diseases 58026 2IOM report released on species jumping diseases 58026 3
...just the climate that is struggling with what huma...eling the pressure as well, according to Professor...Takes a Genome: How a Clash Between Our Genes and ...from UQ,s School of Biological Sciences, suggests ...cancer and Alzheimer,s are due to human genes bein...
...f leading UK scientists and social scientists led ...y of Edinburgh, calls for joined-up thinking on th... gold. The world is waking up to the potential of ...o carbon sinks, there is growing talk of plants re...my. , But such fame comes at a price. , Recent...
...a from the satellite-based MIPAS and GOME-2 instru... important bromine species in the atmosphere. Thes...understand sources of ozone-depleting species and ...istry. , Despite the detection of bromine monoxid...ne nitrate (BrONO2) was first observed in 2008 whe...
Other Biology News:'It takes a genome: How a clash between our genes and modern life is making us sick' 2Plants are political hot potatoes 2European satellites provide new insight into ozone-depleting species 2
Rabbit anti-Alpha-4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Amino Acid Mixture Minus Cysteine from Promega
Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Unconjugated from R&D Systems
CometSlide from R&D Systems
Biology Products: